Adalimumab-Adbm
3 NDCs across 2 manufacturers|2 Generic,1 Brand
Adalimumab-Adbm is used to treat juvenile arthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, crohn disease and hidradenitis suppurativa, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $61 million on Adalimumab-Adbm across 8,014 claims for 1,579 beneficiaries.
Adalimumab-Adbm is available as 3 NDCs from 2 manufacturers (2 generic, 1 brand), with NADAC prices from $638.80 to $3202.75 per EA — the most expensive product costs about 5.0× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
2G / 1B
Manufacturers
2
competing in market
Price Spread
$638.80 – $3202.75
per EA
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing ADALIMUMAB-ADBM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CYLTEZO(CF) PEN 40 MG/0.8 ML | $3202.7520 per EA | — |
ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML | $638.8046 per EA | +0.01% |
ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML | $638.8046 per EA | +0.01% |
Frequently Asked Questions
What is Adalimumab-Adbm used to treat?
Adalimumab-Adbm is used to treat juvenile arthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, crohn disease and hidradenitis suppurativa, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Adalimumab-Adbm?
In 2024, Medicare Part D spent $61 million on Adalimumab-Adbm across 8,014 claims for 1,579 beneficiaries.
How many Adalimumab-Adbm products are on the market?
The Adalimumab-Adbm drug market contains 3 NDCs from 2 manufacturers — 2 generic and 1 brand product.
What is the price range for Adalimumab-Adbm?
NADAC reference prices for Adalimumab-Adbm range from $638.8046 to $3202.7520 per EA — the most expensive product costs about 5.0× the cheapest.
Is generic Adalimumab-Adbm cheaper than brand?
The average generic NADAC for Adalimumab-Adbm is $638.8046 per EA, versus $3202.7520 for brand-labeled products — brand versions average about 5.0× the generic price.
Which manufacturers make Adalimumab-Adbm?
2 manufacturers list Adalimumab-Adbm in NADAC. Ranked by number of NDCs, the largest are Boehringer Ingelheim Pharmaceuticals Inc. (2), Quallent Pharmaceuticals Health LLC (1).
How has the price of Adalimumab-Adbm changed recently?
Over the past 7 days, 2 Adalimumab-Adbm NDCs rose and 0 fell, with a market-wide average change of +0.0%.